Fields of interest
- Pathology of pancreatobiliary disease
- Tumour heterogeneity
- Cancer-stroma interaction
- Chemotherapy-induced changes
- Endocrine neoplasia of the digestive system
Background
- MD: University of Antwerp, Belgium
- Dr med: University of Heidelberg, Germany
- PhD (Habilitation, Priv Doz): University of Heidelberg, Germany
Teaching
- Undergraduate medical students, UiO (module 4 & 8)
- Gastro-intestinal and hepatopancreatobiliary pathology
Commissions of trust
- Member of the European study group on cystic tumours of the pancreas
-
Member of the Norwegian Gastrointestinal Cancer Group-HPB
-
Member of the Research Committee of the Norwegian Pathology Society
-
Member of the Steering committee of the pancreatic biobank, Oslo University Hospital
-
Member of the UICC TNM expert panel for endocrine tumours, Geneva, Switzerland
-
Chair of the ICCR (International Collaboration on Cancer Reporting) Dataset Authoring Committee for pancreatic cancer
-
Member of the International Consensus Workshop for Pancreatic Ductal Adenocarcinoma Taxonomy
-
Member of Pancreatic Cancer Europe - National Support Work Stream
-
Chairman of the patient advocacy group Pancreatic Cancer Network Norway (www.pknn.no)
Emneord:
Pathology,
Pancreatic cancer,
Pancreatitis,
Pancreatic disease,
Neoadjuvant treatment,
Tumour heterogeneity
Publikasjoner
- Campbell F & Verbeke CS. Pathology of the pancreas. A practical approach. Springer 2013 (ISBN 978-1-4471-2449-8)
-
-
-
-
Farnes, Ingvild; Paulsen, Vemund; Verbeke, Caroline Sophie; Tønnesen, Christer Julseth; Aabakken, Lars & Labori, Knut Jørgen
(2023).
Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study.
Scandinavian Journal of Gastroenterology.
ISSN 0036-5521.
0,
s. 1–7.
doi:
10.1080/00365521.2023.2290456.
Fulltekst i vitenarkiv
-
-
-
-
-
Amrutkar, Manoj; Verbeke, Caroline Sophie; Vefferstad, Anette; Dorg, Linda Trobe; Labori, Knut Jørgen & Gladhaug, Ivar Prydz
(2022).
Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma.
Molecular Oncology.
ISSN 1574-7891.
17(1),
s. 59–81.
doi:
10.1002/1878-0261.13344.
Fulltekst i vitenarkiv
Vis sammendrag
he modest clinical benefits of neoadjuvant chemotherapy (NAT) in pancreatic ductal adenocarcinoma (PDAC) are associated with a lack of robust data on treatment-induced changes in the tumor. To this end, comparative proteomic profiling of tumor tissue samples from treatment-naïve (TN, n = 20) and NAT-treated (n = 22) PDACs was performed. Differentially expressed proteins were identified and correlation with overall survival (OS) was performed. Tumors were also examined for histopathological changes and expression of cancer stem cell (CSC) markers. Serum from 33 matched patients was analyzed for metabolic markers. Cytotoxicity, proliferation, and expression of CSC markers were assessed in chemoresistant Panc-1 and Mia PaCa-2 cells. Of the 2265 proteins identified, 227 and 144 proteins showed significantly altered expression and differential phosphorylation, respectively, in NAT compared with TN samples. The majority of these were metabolism-related proteins, and 14 of these correlated moderately with OS. NAT-treated tumors and chemoresistant cancer cells showed increased expression of CSC markers. Serum ALDH1A1 was higher in NAT compared with TN. Differentially phosphorylated proteins were mainly involved in cytoskeleton organization, cell locomotion, motility, and migration, and 17 of these showed a strong positive correlation with OS. This study provides evidence of the effects of NAT on PDAC metabolism at both the tumor and the systemic levels. NAT-treated tumors showed significantly lower expression of metabolic proteins, and patients who underwent NAT showed reduced serum lactate and high-density lipoprotein-cholesterol. Lastly, cancer cells that survived cytotoxic treatment expressed higher CSC markers, both in vivo and in vitro.
-
-
Holm, Maia Blomhoff & Verbeke, Caroline Sophie
(2022).
Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma.
Current Oncology.
ISSN 1198-0052.
29(9),
s. 6551–6563.
doi:
10.3390/curroncol29090515.
Fulltekst i vitenarkiv
-
Tran, My Linh; Holm, Maia Blomhoff & Verbeke, Caroline Sophie
(2022).
Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination Approach.
Cancers.
ISSN 2072-6694.
14(10),
s. 1–17.
doi:
10.3390/cancers14102471.
Fulltekst i vitenarkiv
-
-
-
-
Soer, Eline C. & Verbeke, Caroline Sophie
(2021).
Pathology reporting of margin status in locally advanced
pancreatic cancer: challenges and uncertainties.
Journal of Gastrointestinal Oncology (JGO).
ISSN 2078-6891.
12(5),
s. 2512–2520.
doi:
10.21037/jgo-20-391.
Fulltekst i vitenarkiv
-
van Hilst, Jony; Korrel, Maarten; Lof, Sanne; de Rooij, Thijs; Vissers, Frederique L. & Edwin, Bjørn von Gohren
[Vis alle 50 forfattere av denne artikkelen]
(2021).
Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial.
Trials.
ISSN 1745-6215.
22:608,
s. 1–11.
doi:
10.1186/s13063-021-05506-z.
-
-
-
-
-
Santha, Petra; Lenggenhager, Daniela; Vefferstad, Anette; Dorg, Linda Trobe; Tøndel, Kristin & Amrutkar, Manoj
[Vis alle 8 forfattere av denne artikkelen]
(2021).
Morphological heterogeneity in pancreatic cancer reflects structural and functional divergence.
Cancers.
ISSN 2072-6694.
13(4).
doi:
10.3390/cancers13040895.
Fulltekst i vitenarkiv
Vis sammendrag
Pancreatic cancer has a poor prognosis, which is largely due to resistance to treatment. Tumor heterogeneity is a known cause for treatment failure and has been studied at the molecular level. Morphological heterogeneity is common but has not been investigated, despite the fact that pathology examination is an integral part of clinical diagnostics. This study assessed whether morphological heterogeneity reflects structural and functional diversity in key cancer biological processes. Using archival tissues from resected pancreatic cancer, we selected four common and distinct morphological phenotypes and demonstrated that these differed significantly for a panel of 26 structural and functional features of the cancer-cell and stromal compartments. The strong link between these features and morphological phenotypes allowed prediction of the latter based on the results for the panel of features. The findings of this study indicate that morphological heterogeneity reflects biological diversity and that its assessment may potentially provide clinically relevant information.
-
Esposito, Irene; Hruban, Ralph H.; Verbeke, Caroline Sophie; Terris, Benoit; Zamboni, Giuseppe & Scarpa, Aldo
[Vis alle 20 forfattere av denne artikkelen]
(2020).
Guidelines on the histopathology of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and the European Pancreatic Club.
Pancreatology (Print).
ISSN 1424-3903.
20(4),
s. 586–593.
doi:
10.1016/j.pan.2020.04.009.
-
Cobo, Isidoro; Iglesias, Mar; Flández, Marta; Verbeke, Caroline Sophie; del Pozo, Natalia & Llorente, Miriam
[Vis alle 11 forfattere av denne artikkelen]
(2020).
Epithelial Nr5a2 heterozygosity cooperates with mutant Kras
in the development of pancreatic cystic lesions.
Journal of Pathology.
ISSN 0022-3417.
253(2),
s. 174–185.
doi:
10.1002/path.5570.
-
-
-
-
Wesali, Sahar; Demir, Mehmet A.; Verbeke, Caroline Sophie; Andersson, Mats; Bratlie, Svein Olav & Sadik, Riadh
(2020).
EUS is accurate in characterizing pancreatic cystic lesions; a prospective comparison with cross-sectional imaging in resected cases.
Surgical Endoscopy.
ISSN 0930-2794.
s. 1–10.
doi:
10.1007/s00464-020-08166-3.
Fulltekst i vitenarkiv
-
-
Hugenschmidt, Harald; Labori, Knut Jørgen; Brunborg, Cathrine; Verbeke, Caroline Sophie; Seeberg, Lars Thomas & Schirmer, Cecilie
[Vis alle 10 forfattere av denne artikkelen]
(2020).
Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
.
BMC Cancer.
ISSN 1471-2407.
20:1107,
s. 1–13.
doi:
10.1186/s12885-020-07510-z.
Fulltekst i vitenarkiv
Vis sammendrag
Background: Pancreatic and periampullary carcinoma are aggressive tumours where preoperative assessment is challenging. Disseminated tumour cells (DTC) in the bone marrow (BM) are associated with impaired prognosis in a variety of epithelial cancers. In a cohort of patients with presumed resectable pancreatic and periampullary carcinoma, we evaluated the frequency and the potential prognostic impact of the preoperative presence of DTC, defined as cytokeratin-positive cells detected by immunocytochemistry (ICC).
Methods: Preoperative BM samples from 242 patients selected for surgical resection of presumed resectable pancreatic and periampullary carcinoma from 09/2009 to 12/2014, were analysed for presence of CK-positive cells by ICC. The median observation time was 21.5 months. Overall survival (OS) and disease-free survival (DFS) were calculated by Kaplan-Meier and Cox regression analysis.
Results: Successful resections of malignant tumours were performed in 179 of the cases, 30 patients resected had benign pancreatic disease based on postoperative histology, and 33 were deemed inoperable intraoperatively due to advanced disease. Overall survival for patients with resected carcinoma was 21.1 months (95% CI: 18.0-24.1), for those with benign disease OS was 101 months (95% CI: 69.4-132) and for those with advanced disease OS was 8.8 months (95% CI: 4.3-13.3). The proportion of patients with detected CK-positive cells was 6/168 (3.6%) in resected malignant cases, 2/31 (6.5%) in advanced disease and 4/29 (13.8%) in benign disease. The presence of CK-positive cells was not correlated to OS or DFS, neither in the entire cohort nor in the subgroup negative for circulating tumour cells (CTC).
Conclusions: The results indicate that CK-positive cells may be present in both patients with malignant and benign diseases of the pancreas. Detection of CK-positive cells was not associated with differences in prognosis for the entire cohort or any of the subgroups analysed.
-
Lof, Sanne; Rajak, Rushda; Vissers, Frederique L.; Korrel, Maarten; Bateman, Adrian & Verheij, Johanna
[Vis alle 10 forfattere av denne artikkelen]
(2020).
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens.
Journal of Visualized Experiments.
ISSN 1940-087X.
156:e60343,
s. 1–7.
doi:
10.3791/60343.
-
-
Vujasinovic, Miroslav; Pozzi Mucelli, Raffaella Maria; Valente, Roberto; Verbeke, Caroline Sophie; Haas, Stephan L. & Löhr, J.-Matthias
(2019).
Kidney involvement in patients with type 1 autoimmune pancreatitis.
Journal of Clinical Medicine.
ISSN 2077-0383.
8(2),
s. 1–10.
doi:
10.3390/jcm8020258.
-
-
-
-
Amrutkar, Manoj; Aasrum, Monica; Verbeke, Caroline Sophie & Gladhaug, Ivar Prydz
(2019).
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
BMC Cancer.
ISSN 1471-2407.
19(596).
doi:
10.1186/s12885-019-5803-1.
Fulltekst i vitenarkiv
-
-
Kleive, Dyre; Labori, Knut Jørgen; Line, Pål Dag; Gladhaug, Ivar Prydz & Verbeke, Caroline Sophie
(2019).
Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
HPB.
ISSN 1365-182X.
22(1),
s. 50–57.
doi:
10.1016/j.hpb.2019.05.005.
Fulltekst i vitenarkiv
-
Kamposioras, Konstantinos; Tsimplouli, Chrysiida; Verbeke, Caroline Sophie; Anthoney, Alan; Daoukopoulou, Argyro & Papandreou, Christos N
[Vis alle 13 forfattere av denne artikkelen]
(2018).
Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model.
International Journal of Oncology.
ISSN 1019-6439.
54(2),
s. 537–549.
doi:
10.3892/ijo.2018.4640.
Fulltekst i vitenarkiv
-
-
-
Del Chiaro, Marco; Rangelova, Elena; Halimi, Asif; Ateeb, Zeeshan; Scandavini, Chiara & Valente, Roberto
[Vis alle 9 forfattere av denne artikkelen]
(2018).
Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer.
HPB.
ISSN 1365-182X.
21(2),
s. 219–225.
doi:
10.1016/j.hpb.2018.07.017.
-
Hugenschmidt, Harald; Labori, Knut Jørgen; Brunborg, Cathrine; Verbeke, Caroline Sophie; Seeberg, Lars Thomas & Schirmer, Cecilie
[Vis alle 10 forfattere av denne artikkelen]
(2018).
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
Annals of Surgery.
ISSN 0003-4932.
271(3),
s. 549–558.
doi:
10.1097/SLA.0000000000003035.
-
Löhr, J.-Matthias; Panic, N.; Vujasinovic, Miroslav & Verbeke, Caroline Sophie
(2018).
The ageing pancreas: a systematic review of the evidence and analysis of the consequences.
Journal of Internal Medicine.
ISSN 0954-6820.
283(5),
s. 446–460.
doi:
10.1111/joim.12745.
-
Verbeke, Caroline Sophie; Häberle, Lena; Lenggenhager, Daniela & Esposito, Irene
(2018).
Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on.
Pancreatology (Print).
ISSN 1424-3903.
18(5),
s. 467–476.
doi:
10.1016/j.pan.2018.04.010.
-
Verbeke, Caroline Sophie
(2018).
A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer.
JOURNAL OF IMMUNOTHERAPY.
ISSN 1053-8550.
doi:
10.1097/CJI.0000000000000164.
-
Sahakyan, Mushegh; Haugvik, Sven-Petter; Røsok, Bård Ingvald; Kazaryan, Airazat M.; Ignjatovic, Dejan & Buanes, Trond
[Vis alle 9 forfattere av denne artikkelen]
(2018).
Can standardized pathology examination increase the lymph node yield following laparoscopic distal pancreatectomy for ductal adenocarcinoma?
HPB.
ISSN 1365-182X.
20(2),
s. 175–181.
doi:
10.1016/j.hpb.2017.08.038.
-
Jabbar, Karolina; Sadik, Riadh; Verbeke, Caroline Sophie; Arike, Liisa & Hansson, Gunnar C.
(2018).
Highly accurate identification of cystic precursor lesions of pancreatic cancer through targeted mass spectrometry: a phase IIc diagnostic study.
Journal of Clinical Oncology.
ISSN 0732-183X.
36(4),
s. 367–375.
doi:
10.1200/JCO.2017.73.7288.
-
-
Verbeke, Caroline Sophie
(2017).
Operative Specimen Handling and Evaluation of Resection Margins.
I Kim, Sun Whe & Yamaue, Hiroki (Red.),
Pancreatic Cancer. With Special Focus on Topical Issues and Surgical Techniques.
Springer Publishing Company.
ISSN 978-3-662-47180-7.
s. 67–87.
doi:
10.1007/978-3-662-47181-4_5.
-
Verbeke, Caroline Sophie; Löhr, Matthias; Heuchel, Rainer Lothar & Kartalis, Nikolaos
(2017).
A preliminary report: Radical surgery and stem cell transplantation for the treatment of patients with pancreatic cancer.
JOURNAL OF IMMUNOTHERAPY.
ISSN 1053-8550.
doi:
10.1097/CJI.0000000000000164.
-
Gjelberg, Hilde; Hoem, Dag; Verbeke, Caroline Sophie; Eide, Johan; Cooper, John & Molven, Anders
(2017).
Hypoglycemia and decreased insulin requirement caused by malignant insulinoma in a type 1 diabetic patient: when the hoof beats are from a zebra, not a horse.
Clinical Case Reports.
ISSN 2050-0904.
5(6),
s. 761–768.
doi:
10.1002/ccr3.927.
Fulltekst i vitenarkiv
-
-
-
-
-
-
-
Del Chiaro, Marco & Verbeke, Caroline Sophie
(2017).
Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features.
Histopathology.
ISSN 0309-0167.
70(6),
s. 850–860.
doi:
10.1111/his.13131.
-
Tjomsland, Vegard; Pomianowska, Ewa; Aasrum, Monica; Sandnes, Dagny Lise; Verbeke, Caroline Sophie & Gladhaug, Ivar Prydz
(2016).
Profile of MMP and TIMP expression in human pancreatic stellate cells: regulation by IL-1? and TGF? and implications for migration of pancreatic cancer cells.
Neoplasia.
ISSN 1522-8002.
18(7),
s. 447–456.
doi:
10.1016/j.neo.2016.06.003.
-
-
Kleive, Dyre; Berstad, Audun Elnæs; Verbeke, Caroline Sophie; Haugvik, Sven-Petter; Gladhaug, Ivar Prydz & Line, Pål Dag
[Vis alle 7 forfattere av denne artikkelen]
(2016).
Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery.
HPB.
ISSN 1365-182X.
18(7),
s. 615–622.
doi:
10.1016/j.hpb.2016.05.010.
Vis sammendrag
Background SMV/PV resection has become common practice in pancreatic surgery. The aim of this study was to evaluate the technical feasibility and surgical outcome of using cold-stored cadaveric venous allografts (AG) for superior mesenteric vein (SMV) and portal vein (PV) reconstruction during pancreatectomy. Methods Patients who underwent pancreatic resection with concomitant vascular resection and reconstruction with AG between January 2006 and December 2014 were identified from our institutional prospective database. Medical records and pre- and postoperative CT-images were reviewed. Results Forty-five patients underwent SMV/PV reconstruction with AG interposition (n = 37) or AG patch (n = 8). The median operative time and blood loss were 488 min (IQR: 450–551) and 900 ml (IQR: 600-2000), respectively. Major morbidity (Clavien ≥ III) occurred in 16 patients. Four patients were reoperated (thrombosis n = 2, graft kinking/low flow n = 2) and in-hospital mortality occurred in two patients. On last available CT scan, 3 patients had thrombosis, all of whom also had local recurrence. Estimated cumulative patency rate (reduction in SMV/PV luminal diameter <70% and no thrombosis) at 12 months was 52%. Conclusion Cold-stored cadaveric venous AG for SMV/PV reconstruction during pancreatic surgery is safe and associated with acceptable long-term patency.
-
Fernández Moro, Carlos; Fernandez-Woodbridge, Alejandro; D'souza,, Melroy Alistair; Zhang,, Qianni; Bozoky, Benedek & Kandaswamy, Senthil Vasan
[Vis alle 16 forfattere av denne artikkelen]
(2016).
Immunohistochemical typing of adenocarcinoma of the pancreatobiliary system improves diagnosis and prognostic stratification.
PLOS ONE.
ISSN 1932-6203.
11.
doi:
10.1371/journal.pone.0166067.
-
-
Verbeke, Caroline Sophie
(2016).
Expansion of tumor-reactive T cells from patients with pancreatic cancer.
JOURNAL OF IMMUNOTHERAPY.
ISSN 1053-8550.
30,
s. 81–90.
doi:
10.1097/cji.0000000000000111.
-
-
Haugvik, Sven-Petter; Kaemmerer, Daniel; Gaujoux, Sebastien; Labori, Knut Jørgen; Verbeke, Caroline Sophie & Gladhaug, Ivar Prydz
(2016).
Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.
Current Oncology Reports.
ISSN 1523-3790.
18(5).
doi:
10.1007/s11912-016-0518-9.
-
Verbeke, Caroline Sophie
(2016).
Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter?
Pancreatology (Print).
ISSN 1424-3903.
16(3),
s. 295–301.
doi:
10.1016/j.pan.2016.02.004.
-
-
Verbeke, Caroline Sophie & Gladhaug, Ivar Prydz
(2012).
Resection margin involvement and tumour origin in pancreatic head cancer.
British Journal of Surgery.
ISSN 0007-1323.
99(8),
s. 1036–1049.
doi:
10.1002/bjs.8734.
-
Verbeke, Caroline Sophie; Knapp, Johannes & Gladhaug, Ivar Prydz
(2011).
Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment.
Histopathology.
ISSN 0309-0167.
59(6),
s. 1111–1121.
doi:
10.1111/j.1365-2559.2011.04056.x.
Se alle arbeider i Cristin
-
Henmo, Ola; Helland, Åslaug; Mala, Tom; Verbeke, Caroline Sophie & Bjerkvig, Rolf
(2023).
Dette superteamet skal løse våre største kreftutfordringer.
[Fagblad].
Forskning.no.
-
Schuurmans, Megan; Alves, Natália; Vendittelli, Pierpaolo; Huisman, Henkjan; Hermans, John & Litjens, Geert
[Vis alle 10 forfattere av denne artikkelen]
(2023).
Artificial Intelligence in Pancreatic Ductal Adenocarcinoma Imaging: A Commentary on Potential Future Applications.
Gastroenterology.
ISSN 0016-5085.
165(2),
s. 309–316.
doi:
10.1053/j.gastro.2023.04.003.
-
Resell, Mathilde Victoria; Rabben, Hanne-Line; Amrutkar, Manoj; Hagen, Lars; Batra, Surinder K. & Verbeke, Caroline Sophie
[Vis alle 9 forfattere av denne artikkelen]
(2023).
Mo1138 COMPARATIVE PROTEOMICS REVEALS TRANSLATIONAL POTENTIAL OF TARGETS FOR PANCREATIC DUCTAL ADENOCARCINOMA.
Gastroenterology.
ISSN 0016-5085.
164(6),
s. S-771–S-771.
-
Resell, Mathilde Victoria; Rabben, Hanne-Line; Amrurkar, Manoj; Hagen, Lars; Batra, Surinder K. & Verbeke, Caroline Sophie
[Vis alle 9 forfattere av denne artikkelen]
(2023).
COMPARATIVE PROTEOMICS REVEALS TRANSLATIONAL POTENTIAL OF TARGETS FOR PANCREATIC DUCTAL ADENOCARCINOMA.
-
Arnelo, Urban; Rangelova, Elena; Del Chiaro, Marco; Valente, Roberto & Verbeke, Caroline Sophie
(2019).
RE: correct reporting is of utmost importance when a controversial treatment is being evaluated.
HPB.
ISSN 1365-182X.
21(9),
s. 1251–1252.
doi:
10.1016/j.hpb.2019.04.009.
-
Del Chiaro, Marco; Arnelo, Urban; Rangelova, Elena; Valente, Roberto & Verbeke, Caroline Sophie
(2019).
RE: Pancreatectomy with arterial resection.
HPB.
ISSN 1365-182X.
21(9),
s. 1254–1255.
doi:
10.1016/j.hpb.2019.06.003.
-
Kartalis, Nikolaos; Rinta-Kiikka, Irina; Wünsche, Katharina; Laukkarinen, Johanna; Labori, Knut Jørgen & Ånonsen, Kim Vidar
[Vis alle 9 forfattere av denne artikkelen]
(2015).
Pancreatic MRI for the follow-up of cystic neoplasms: Comparison of a short with a comprehensive imaging protocol.
-
Labori, Knut Jørgen; Verbeke, Caroline Sophie & Gladhaug, Ivar Prydz
(2015).
Information needs among patients and a surveillance strategy after surgery for pancreatic and periampullary cancer.
HPB Surgery.
ISSN 0894-8569.
17(7).
doi:
10.1111/hpb.12411.
Se alle arbeider i Cristin
Publisert
18. nov. 2014 14:44
- Sist endret
1. sep. 2022 14:34